InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $74.14 million. The enterprise value is $50.62 million.
Important Dates
The next confirmed earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 30.64 million shares outstanding. The number of shares has increased by 48.89% in one year.
| Current Share Class | 30.64M |
| Shares Outstanding | 30.64M |
| Shares Change (YoY) | +48.89% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | 25.43% |
| Owned by Institutions (%) | 23.02% |
| Float | 16.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.93 |
| Forward PS | 8.78 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.36 |
| Quick Ratio | 3.86 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -113.95% and return on invested capital (ROIC) is -69.83%.
| Return on Equity (ROE) | -113.95% |
| Return on Assets (ROA) | -58.16% |
| Return on Invested Capital (ROIC) | -69.83% |
| Return on Capital Employed (ROCE) | -119.95% |
| Revenue Per Employee | $81,709 |
| Profits Per Employee | -$420,221 |
| Employee Count | 86 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, InspireMD has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.81% in the last 52 weeks. The beta is 0.57, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -26.81% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 2.64 |
| Relative Strength Index (RSI) | 47.11 |
| Average Volume (20 Days) | 69,639 |
Short Selling Information
The latest short interest is 375,897, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 375,897 |
| Short Previous Month | 320,682 |
| Short % of Shares Out | 1.23% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 0.98 |
Income Statement
In the last 12 months, InspireMD had revenue of $7.03 million and -$36.14 million in losses. Loss per share was -$0.79.
| Revenue | 7.03M |
| Gross Profit | 1.51M |
| Operating Income | -37.55M |
| Pretax Income | -25.46M |
| Net Income | -36.14M |
| EBITDA | -37.24M |
| EBIT | -37.55M |
| Loss Per Share | -$0.79 |
Full Income StatementBalance Sheet
The company has $26.09 million in cash and $2.32 million in debt, giving a net cash position of $23.76 million or $0.78 per share.
| Cash & Cash Equivalents | 26.09M |
| Total Debt | 2.32M |
| Net Cash | 23.76M |
| Net Cash Per Share | $0.78 |
| Equity (Book Value) | 28.35M |
| Book Value Per Share | 0.95 |
| Working Capital | 24.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.60 million and capital expenditures -$1.57 million, giving a free cash flow of -$27.16 million.
| Operating Cash Flow | -25.60M |
| Capital Expenditures | -1.57M |
| Free Cash Flow | -27.16M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | 21.43% |
| Operating Margin | -534.35% |
| Pretax Margin | -513.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -48.89% |
| Shareholder Yield | -48.89% |
| Earnings Yield | -48.59% |
| FCF Yield | -36.52% |
Analyst Forecast
The average price target for InspireMD is $4.50, which is 85.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 85.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -7.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.89 |
| Piotroski F-Score | 1 |
